Dr. Rescigno is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
61 E 77th St
New York, NY 10075Phone+1 212-722-2130Fax+1 212-722-2147
Education & Training
Memorial Sloan Kettering Cancer CenterResidency, Radiation Oncology, 1991 - 1995
Icahn School of Medicine at Mount Sinai/Beth IsraelInternship, Internal Medicine, 1990 - 1991
New York University School of MedicineClass of 1990
Certifications & Licensure
NY State Medical License 1991 - 2025- American Board of Radiology Radiation Oncology
Clinical Trials
- Neoadjuvant CAPOXIRI Chemotherapy in the Treatment of Pancreatic Adenocarcinoma Protocol Start of enrollment: 2011 Dec 01
Publications & Presentations
PubMed
- 59 citationsAcute toxicity of high-dose-rate intracavitary brachytherapy with the MammoSite applicator in patients with early-stage breast cancer.Gregory M. Richards, Anthony M. Berson, John Rescigno, Seema Sanghavi, Beth Siegel
Annals of Surgical Oncology. 2004-07-12 - 82 citationsPatterns of Axillary Surgical Care for Breast Cancer in the Era of Sentinel Lymph Node BiopsyJohn Rescigno, Jamie C. Zampell, Deborah Axelrod
Annals of Surgical Oncology. 2009-03-01 - 106 citationsInvasive Anal Squamous-Cell Carcinoma in the HIV-Positive Patient: Outcome in the Era of Highly Active Antiretroviral TherapyAnn Wexler, Anthony M. Berson, Stephen E. Goldstone, Roger J. Waltzman, Jason R. Penzer
Diseases of the Colon and Rectum. 2008-01-01
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
